Document Detail


A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
MedLine Citation:
PMID:  352236     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A sixteen-week study examined the effect of Madopa and Sinemet on patients with Parkinson disease disease suffering nausea or vomiting as side-effects of levodopa therapy and compared the efficacy of the three preparations in controlling the symptoms of Parkinson disease. Following a control period on levodopa, 20 patients underwent four consecutive four-week regimens as follows: (1) double-blind, in which a randomized half received levodopa and half received Madopa; (2) single-blind, in which all received Madopa; (3) double-blind, in which a re-randomized half received Madopa and half Sinemet; and (4) single-blind, in which all received Sinemet. Levodopa administration via Sinemet and Madopa was held to a fixed 20% of prior levodopa dosage. Almost all patients showed great reduction in nausea and vomiting with both Madopa and Sinemet. Seventy percent of the patients showed improvement in disability compared to their levodopa baseline levels. Group means showed no difference between the improvement seen on Madopa and that seen on Sinemet. However, examination of individual responses showed that the majority of patients fared distinctly better on either Sinemet or Madopa.
Authors:
S G Diamond; C H Markham; L J Treciokas
Related Documents :
21255806 - Modified scrotal (bianchi) mid raphe single incision orchiopexy for low palpable undesc...
15061246 - Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia.
288486 - Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia.
21467796 - Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resis...
16800986 - Effects of kanlijian on exercise tolerance, quality of life, and frequency of heart fai...
21346586 - The shang ring device for adult male circumcision: a proof of concept study in kenya.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Annals of neurology     Volume:  3     ISSN:  0364-5134     ISO Abbreviation:  Ann. Neurol.     Publication Date:  1978 Mar 
Date Detail:
Created Date:  1978-08-14     Completed Date:  1978-08-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7707449     Medline TA:  Ann Neurol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  267-72     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Benserazide / administration & dosage*,  therapeutic use
Carbidopa / administration & dosage*,  therapeutic use
Clinical Trials as Topic
Double-Blind Method
Drug Combinations
Female
Humans
Hydrazines / administration & dosage*
Levodopa / administration & dosage*,  adverse effects,  therapeutic use
Male
Middle Aged
Nausea / chemically induced
Parkinson Disease / drug therapy*
Vomiting / chemically induced
Chemical
Reg. No./Substance:
0/Drug Combinations; 0/Hydrazines; 0/Levodopa; 322-35-0/Benserazide; 38821-49-7/Carbidopa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Deafness due to renal failure. Clinicopathological study (author's transl)
Next Document:  Virus envelopes and plasma membranes.